PerkinElmer Plans Acquisitions in 06; Will Increase Focus on Proteomics Dx Play | GenomeWeb

PerkinElmer is targeting acquisitions and additional alliances in 2006 as it places greater emphasis on its health sciences operations and looks to expand its growth platforms, company officials recently said in a conference call.

Specifically, company officials said the firm will expand its drug-discovery tool portfolio "to include next-generation proteomics diagnostics," including reagents for biomarker discovery.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.